Novel methods to monitor antigen-specific cytotoxic T-cell responses in cancer immunotherapy

van der Bruggen, 1991, A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma, Science, 254, 1643, 10.1126/science.1840703 Coulie, 1997, Human tumour antigens recognized by T cells: new perspectives for anti-cancer vaccines, Mol. Med. Today, 3, 261, 10.1016/S1357-4310(97)01049-6 Boniface, 1995, T-cell recognition of antigen. A process controlled by transient intermolecular interactions, Ann. New York Acad. Sci., 766, 62, 10.1111/j.1749-6632.1995.tb26649.x Rivoltini, 1995, Induction of tumor-reactive CTL from peripheral blood and tumor-infiltrating lymphocytes of melanoma patients by in vitro stimulation with an immunodominant peptide of the human melanoma antigen MART-1, J. Immunol., 154, 2257, 10.4049/jimmunol.154.5.2257 Jäger, 1996, Generation of cytotoxic T cell responses with synthetic melanoma associated peptides in vivo, implications for tumor vaccines with melanoma associated antigens, Int. J. Cancer, 66, 162, 10.1002/(SICI)1097-0215(19960410)66:2<162::AID-IJC4>3.0.CO;2-0 Yee, 1997, Prospects for adoptive T cell therapy, Curr. Opin. Immunol., 9, 702, 10.1016/S0952-7915(97)80052-0 Sharrock, 1990, Limiting dilution analysis of human T cells: a useful clinical tool, Immunol. Today, 11, 281, 10.1016/0167-5699(90)90113-N Taswell, 1981, Limiting dilution assay for the determination of immunocompetent cell frequencies. I. Data analysis, J. Immunol., 126, 1614, 10.4049/jimmunol.126.4.1614 Brunner, 1968, Quantitative assay of the lytic action of immune lymphoid cells on 51Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs, Immunology, 14, 181 Marchand, 1995, Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3, Int. J. Cancer, 63, 883, 10.1002/ijc.2910630622 Tsang, 1995, Generation of human cytotoxic T cells specific for human carcinoembryonic antigen epitopes from patients immunized with recombinant vaccinia-CEA vaccine, J. Natl. Cancer Inst., 87, 982, 10.1093/jnci/87.13.982 Salgaller, 1996, Immunization against epitopes in the human melanoma antigen gp100 following patient immunization with synthetic peptides, Cancer Res., 56, 4749 Cormier, 1997, Enhancement of cellular immunity in melanoma patients immunized with a peptide from MART-1/Melan-A, Cancer J. Sci. Am., 3, 37 Romagnani, 1995, Biology of human Th1 and Th2 cells, J. Clin. Immunol., 15, 121, 10.1007/BF01543103 Carter, 1997, Single cell analyses of cytokine production, Curr. Opin. Immunol., 9, 177, 10.1016/S0952-7915(97)80132-X Hoefakker, 1995, Detection of human cytokines in situ using antibody and probe based methods, J. Immunol. Methods, 185, 149, 10.1016/0022-1759(95)00122-Q Jung, 1993, Detection of intracellular cytokines by flow cytometry, J. Immunol. Methods, 159, 197, 10.1016/0022-1759(93)90158-4 Prussin, 1995, Detection of intracytoplasmic cytokine using flow cytometry and directly conjugated anti-cytokine antibodies, J. Immunol. Methods, 188, 117, 10.1016/0022-1759(95)00209-X Waldrop, 1997, Determination of antigen-specific memory/effector CD4+ T cell frequencies by flow cytometry: evidence for a novel, antigen-specific homeostatic mechanism in HIV-associated immunodeficiency, J. Clin. Invest., 99, 1739, 10.1172/JCI119338 Fonteneau, 1997, Heterogeneity of biologic responses of melanoma-specific CTL, J. Immunol., 159, 2831, 10.4049/jimmunol.159.6.2831 Herr, 1996, Detection and quantification of blood-derived CD8+ T lymphocytes secreting tumor necrosis factor alpha in response to HLA-A2.1-binding melanoma and viral peptide antigens, J. Immunol. Methods, 191, 131, 10.1016/0022-1759(96)00007-5 Scheibenbogen, 1997, Analysis of the T cell response to tumor and viral peptide antigens by an IFNgamma-ELISPOT assay, Int. J. Cancer, 71, 932, 10.1002/(SICI)1097-0215(19970611)71:6<932::AID-IJC3>3.0.CO;2-Z Herr, 1997, The use of computer-assisted video image analysis for the quantification of CD8+ T lymphocytes producing tumor necrosis factor alpha spots in response to peptide antigens, J. Immunol. Methods, 203, 141, 10.1016/S0022-1759(97)00019-7 Casanova, 1993, Antigen-selected T-cell receptor diversity and self-nonself homology, Immunol. Today, 14, 391, 10.1016/0167-5699(93)90140-G Kalams, 1994, Longitudinal analysis of T cell receptor (TCR) gene usage by human immunodeficiency virus 1 envelope-specific cytotoxic T lymphocyte clones reveals a limited TCR repertoire, J. Exp. Med., 179, 1261, 10.1084/jem.179.4.1261 Argaet, 1994, Dominant selection of an invariant T cell antigen receptor in response to persistent infection by Epstein–Barr virus, J. Exp. Med., 180, 2335, 10.1084/jem.180.6.2335 Lehner, 1995, Human HLA-A0201-restricted cytotoxic T lymphocyte recognition of influenza A is dominated by T cells bearing the Vβ 17 gene segment, J. Exp. Med., 181, 79, 10.1084/jem.181.1.79 Pannetier, 1995, T-cell repertoire diversity and clonal expansions in normal and clinical samples, Immunol. Today, 16, 176, 10.1016/0167-5699(95)80117-0 Cole, 1994, The MHC class I-restricted T cell response to Sendai virus infection in C57BL/6 mice: a single immunodominant epitope elicits an extremely diverse repertoire of T cells, Int. Immunol., 6, 1767, 10.1093/intimm/6.11.1767 Sensi, 1995, Cytotoxic T-lymphocyte clones from different patients display limited T-cell-receptor variable-region gene usage in HLA-A2-restricted recognition of the melanoma antigen Melan-A/MART-1, Proc. Natl. Acad. Sci. U. S. A., 92, 5674, 10.1073/pnas.92.12.5674 Romero, 1995, Multiple specificities in the repertoire of a melanoma patient's cytolytic T lymphocytes directed against tumor antigen MAGE-1.A1, J. Exp. Med., 182, 1019, 10.1084/jem.182.4.1019 Romero, 1997, Cytolytic T lymphocyte recognition of the immunodominant HLA-A*0201 restricted Melan-A/MART-1 antigenic peptide in melanoma, J. Immunol., 159, 2366, 10.4049/jimmunol.159.5.2366 Mackensen, 1994, Direct evidence to support the immunosurveillance concept in a human regressive melanoma, J. Clin. Invest., 93, 1397, 10.1172/JCI117116 Sensi, 1997, Clonal expansion of T lymphocytes in human melanoma metastasis after treatment with a hapten-modified autologous tumor vaccine, J. Clin. Invest., 99, 710, 10.1172/JCI119215 Waanders, 1997, Melanoma-reactive human cytolytic T lymphocytes derived from skin biopsies of delayed-type hypersensitivity reactions induced by injection of an autologous melanoma cell line, Clin. Cancer Res., 3, 685 Miescher, 1988, Preferential clonogenic deficit of CD8-positive T lymphocytes infiltrating human solid tumors, Cancer Res., 48, 6992 Pantaleo, 1990, Defective clonogenic potential of CD8+ T lymphocytes in patients with AIDS. Expansion in vivo of a nonclonogenic CD3+CD8+DR+CD25−T cell population, J. Immunol., 144, 1696, 10.4049/jimmunol.144.5.1696 Bieganowska, 1997, Direct ex vivo analysis of activated, fas-sensitive autoreactive T cells in human autoimmune disease, J. Exp. Med., 185, 1585, 10.1084/jem.185.9.1585 Altman, 1996, Phenotypic analysis of antigen-specific T lymphocytes, Science, 274, 94, 10.1126/science.274.5284.94 Murali-Krishna, 1998, Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection, Immunity, 8, 177, 10.1016/S1074-7613(00)80470-7 Parkhurst, 1996, Improved induction of melanoma-reactive CTL with peptides from the melanoma antigen gp100 modified HLA-A*0201-binding residues, J. Immunol., 157, 2539, 10.4049/jimmunol.157.6.2539 Bakker, 1997, Analogues of CTL epitopes with improved MHC class-I binding capacity elicit anti-melanoma CTL recognizing the wild-type epitope, Int. J. Cancer, 70, 302, 10.1002/(SICI)1097-0215(19970127)70:3<302::AID-IJC10>3.0.CO;2-H Valmori, 1998, Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A/MART-1 immunodominant peptide analogs, J. Immunol., 160, 1750, 10.4049/jimmunol.160.4.1750 Luescher, 1996, HLA photoaffinity labeling reveals overlapping binding of homologous MAGE peptides by HLA-A1, HLA-29 and HLA-B44, J. Biol. Chem., 271, 12463, 10.1074/jbc.271.21.12463 Moretta, 1983, Quantitative assessment of the pool size and subset distribution of cytolytic T lymphocytes within human resting or alloactivated peripheral blood T cell populations, J. Exp. Med., 158, 571, 10.1084/jem.158.2.571 Hoffenbach, 1989, Unusually high frequencies of HIV-specific cytotoxic T lymphocytes in humans, J. Immunol., 142, 452, 10.4049/jimmunol.142.2.452 Coulie, 1992, Precursor frequency analysis of human cytolytic T lymphocytes directed against autologous melanoma cells, Int. J. Cancer, 50, 289, 10.1002/ijc.2910500220 Nelson, 1996, Tumor-specific, cytotoxic T-lymphocyte response after idiotype vaccination for B-cell, non-Hodgkin's lymphoma, Blood, 88, 580, 10.1182/blood.V88.2.580.bloodjournal882580